United States · FDA National Drug Code directory
Pirfenidone
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 42385-923_487408e2-1370-400a-a513-8de1d662defa
- Product NDC
- 42385-923
- Form
- CAPSULE
- Composition / generic term
- Pirfenidone
- Labeler
- Laurus Labs Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20220719
- Source listing expiry
- 20261231
Source-listed ingredients
- PIRFENIDONE — 267 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 270 CAPSULE in 1 BOTTLE (42385-923-29) · 42385-923-29
- 4 BLISTER PACK in 1 CARTON (42385-923-54) / 63 CAPSULE in 1 BLISTER PACK · 42385-923-54
- 2 BLISTER PACK in 1 CARTON (42385-923-63) / 21 BLISTER PACK in 1 BLISTER PACK / 42 CAPSULE in 1 BLISTER PACK · 42385-923-63
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →